XyloCor Therapeutics Investors

25 investors on Angel Roster list XyloCor Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, Canada and the Netherlands.

Investors are matched on the company name in their portfolio, so companies that share the name XyloCor Therapeutics can appear together.

Investors listed
25
With verified email
44%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 25 XyloCor Therapeutics investors

The most complete profiles first. Showing 25 of 25.

  • Christoph WestphalVerified

    Venture Capital, Founder, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 24 more

    Verified email available

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Rich AldrichVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • David DonabedianVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Verified email available

  • Gerry BrunkVerified

    Venture Capital, Private Equity Firm, Micro VC · United States

    Health CareWomen FoundedBiotechnologyLending

    Portfolio: Cardiac Dimensions, Exact Imaging, Notch Therapeutics, Social Change Rewards and 36 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Lu HanVerified

    Venture Capital · Canada

    Health CareWomen FoundedBiotechnologyDeveloper Tools

    Portfolio: Cardiac Dimensions, Exact Imaging, Notch Therapeutics, Social Change Rewards and 36 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Nikhil ThatteVerified

    Venture Capital, Private Equity Firm, Micro VC · Canada

    Health CareWomen FoundedBiotechnologyLending

    Portfolio: Cardiac Dimensions, Exact Imaging, Notch Therapeutics, Social Change Rewards and 36 more

    Verified email available

  • Drew Burdon

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Martijn Kleijwegt

    Venture Capital, Private Equity Firm, Investor · Netherlands

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Rudy Dekeyser

    Venture Capital, Private Equity Firm, Investor · Belgium

    Series BHealth CareHospitalsLife ScienceMobile

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Vincent Brichard

    Private Equity Firm, Investor · Netherlands

    SeedHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Baye Galligan

    Venture Capital, Private Equity Firm, Micro VC · Canada

    Health CareWomen FoundedBiotechnologyLending

    Portfolio: Cardiac Dimensions, Exact Imaging, Notch Therapeutics, Social Change Rewards and 36 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Jacki Jenuth

    Venture Capital · Canada

    Health CareWomen FoundedBiotechnologyDeveloper Tools

    Portfolio: Cardiac Dimensions, Exact Imaging, Notch Therapeutics, Social Change Rewards and 36 more

    Contact details available

  • Lea Hachigian

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Contact details available

  • Merijn Klaassen

    Private Equity Firm · Netherlands

    Health CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Richard Glickman

    Venture Capital · Canada

    Health CareWomen FoundedBiotechnologyDeveloper Tools

    Portfolio: Cardiac Dimensions, Exact Imaging, Notch Therapeutics, Social Change Rewards and 36 more

    Contact details available

  • Vasco Larcina

    Venture Capital · Canada

    Health CareWomen FoundedBiotechnologyDeveloper Tools

    Portfolio: Cardiac Dimensions, Exact Imaging, Notch Therapeutics, Social Change Rewards and 36 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many XyloCor Therapeutics investors are on Angel Roster?

Angel Roster lists 25 XyloCor Therapeutics investors. 11 of them (44%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (23), Private Equity Firms (10) and Micro VC Firms (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do XyloCor Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (7) and Series B (4).

Where are XyloCor Therapeutics investors based?

Most are based in the United States (13), Canada (7) and the Netherlands (3).

Which companies have XyloCor Therapeutics investors backed?

The most-backed portfolio companies among them are First Aid Shot Therapy (16), Rainier Therapeutics (14), Merus (14), Endotronix (12) and Cardiac Dimensions (12).

How do I contact XyloCor Therapeutics investors?

Create a free Angel Roster account to search and filter all 25, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.